Product
ReGen-GF
1 clinical trial
2 indications
Indication
Cutis Laxa FacialisIndication
XerodermaClinical trial
A Phase IV Open-label Trial Assessing the Impact on Skin Quality, Hydration, and Barrier of Three (3) Hydrafacial Treatments in Adults of Fitzpatrick Skin Types I-VIStatus: Not yet recruiting, Estimated PCD: 2024-05-01